(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanamine, 97%, 250mg

Viales criogénicos con rosca exterior independiente, 3 ml, junta labial + junta de silicona, 100 pieza(s)

4-(4-Chloro-phenyl)-5-methyl-thiazol-2-ylamine, 95.0%, 100mg

3-Methyl-4-((E)-4-phenyl-but-3-enyl)-piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-Chloro-5-(trifluoromethyl)aniline hydrochloride, 95.0%, 1g

3-Chloro-5-nitrobenzonitrile, 95.0%, 25g

2,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 98.0%, 5g

4,6-Dibromo-3H-benzoimidazol-5-ylamine, 97.0%, 5g

(R)-1-Boc-3-Hydroxymethylpyrrolidine, 95.0%, 1g

1,4-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene, 98%, 250mg

Ácido isobutírico, >=99%, para síntesis, 250 ml, envase de vidrio

5-(4-Pyridyl)-1H-tetrazole, 98.0%, 1g

3-Fluoro-4-(trifluoromethoxy)benzyl alcohol, 95.0%, 1g